跳至主要内容
临床试验/NCT06671431
NCT06671431已完成不适用

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma: a Retrospective Cohort Study

Seoul National University Hospital0 个研究点目标入组 578 人开始时间: 2000年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
578
主要终点
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

研究概览

简要总结

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with distal cholangiocarcinoma who underwent surgery

排除标准

  • Who underwent neoadjuvant treatment
  • Who underwent R2 resection
  • Non-adenocarcinoma patients in final pathology report
  • Insufficient data
  • Death within 90days of surgery

结局指标

主要结局

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

时间窗: From January 2000 to December 2021

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验